Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. · 2017
Read Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. by Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5491694.txt.
Introduction
Omata and co-authors present updated clinical guidelines in Hepatology International on liver cancer care. Hepatocellular carcinoma makes up over 90 percent of liver cancers. Most cases worldwide occur in the Asia-Pacific region. Hepatitis B and C infections cause about 80 percent of cases. The guidelines come from the Asia-Pacific liver association's expert panel.
This update revises the panel's earlier guidance. Advice is graded by the strength of its evidence. Topics run from risk factors and screening to treatment choices. Cirrhosis stands out as the single biggest risk factor. The authors aim for advice that fits the region's varied medical settings.
Catalog record
| CREATOR | Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 309 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |